FOX 9 Minneapolis-St. Paul on MSN1d
Generic prescription drug prices marked up as high as 5,000%, investigation findsA new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen.
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
The term Web Client Runtime Security (WCRS) was coined by the authors to highlight the security or possible malicious ...
The FTC analyzed data for 51 specialty generic drugs dispensed from 2017-2022 for patients with commercial insurance or Medicare Part D plans managed by CVS Caremark, Express Scripts and OptumRx.
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.
FTC Chair Lina Khan has the big three pharmacy benefit managers in sight—UnitedHealth's OptumRx, Cigna's Express Scripts and CVS Caremark Rx. © 2024 Fortune Media ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback